You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent salivary gland cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

Not yet recruiting
  • Salivary Gland Cancer
  • Observation
  • (no location specified)
Oct 13, 2023

Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)

Not yet recruiting
  • Gland
  • Salivary Gland Cancers
  • Sacituzumab Govitecan
  • Houston, Texas
    M D Anderson Cancer Center
May 22, 2023

Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

Recruiting
  • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2023

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +4 more
  • New York, New York
    Memorial Sloane Kettering Cancer Center
Jan 11, 2023

Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer Trial in Boston (9-ING-41, Carboplatin)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 15, 2021

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +5 more
  • Pembrolizumab
  • Pemetrexed Disodium
  • Scottsdale, Arizona
  • +2 more
Mar 15, 2022

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Salivary Gland Cancer Trial in Cincinnati (Amivantamab)

Recruiting
  • Salivary Gland Cancer
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Aug 5, 2022

Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)

Recruiting
  • Adenoid Cystic Carcinoma
  • Salivary Gland Cancer
  • Miami, Florida
  • +7 more
Oct 26, 2022

Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Feb 18, 2022

Salivary Gland Carcinoma, Metastatic Cancer, Recurrent Cancer Trial in France (Nivolumab)

Completed
  • Salivary Gland Carcinoma
  • +2 more
  • Bordeaux, France
  • +10 more
Jan 10, 2022

Recurrent Salivary Gland Infections in Covid-19 Trial in Banha

Active, not recruiting
  • Recurrent Salivary Gland Infections in Covid-19
    • Banhā, Egypt
      Benha university hospitals
    Jun 2, 2023

    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

    Completed
    Has Results
    • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
    • +35 more
    • PI3K inhibitor BKM120
    • cetuximab
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Sep 14, 2021

    PSMA-PET Imaging of Salivary Gland Tumours and Other Rare

    Recruiting
    • Salivary Gland Tumor
    • Rare Malignant Neoplasm
    • 68-Ga PSMA PET scan
    • Singapore, Singapore
      National Cancer Centre Singapore
    Oct 11, 2022

    Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

    Recruiting
    • Salivary Gland Cancer
    • +2 more
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    Oct 27, 2022

    Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

    Recruiting
    • Salivary Gland Carcinoma
    • Chicago, Illinois
    • +6 more
    Sep 22, 2022

    Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

    Completed
    Has Results
    • Caregiver
    • +37 more
    • Communication Intervention
    • +5 more
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Dec 14, 2022

    Head Neck Cancers - Salivary Gland Trial in Shanghai (Surufatinib)

    Recruiting
    • Head and Neck Cancers - Salivary Gland
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    May 28, 2021

    Salivary Gland Cancer, HER2 Gene Mutation Trial in Boston (Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy,

    Recruiting
    • Salivary Gland Cancer
    • HER2 Gene Mutation
    • Ado-trastuzumab (T) emtansine (T-DM1)
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Jan 2, 2023

    Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

    Withdrawn
    • Salivary Gland Carcinoma
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Feb 5, 2022

    Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

    Not yet recruiting
    • Salivary Gland Cancer
    • vedicitumomab (Edisil, RC48）
    • +3 more
    • (no location specified)
    Jun 9, 2023

    Head Neck Cancer Trial in Groningen (Submandibular Gland Stem Cell Transplantation)

    Recruiting
    • Head and Neck Cancer
    • Submandibular Gland Stem Cell Transplantation
    • Groningen, Netherlands
      UMCG
    May 24, 2022

    Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

    Recruiting
    • Salivary Gland Cancer
    • Nagoya, Aichi, Japan
    • +11 more
    Jan 21, 2023

    Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)

    Recruiting
    • Malignant Salivary Gland Cancer
    • Salivary Gland Cancer
    • Tampa, Florida
    • +2 more
    Feb 10, 2022